Download Files:
Products Details
Product Description
– Ritivixibat is an inhibitor of ileal bile acid transporter (IBAT), as well as a bile acid modulator. Ritivixibat can be used for research of cardiovascular diseases, fatty acid metabolism and glucose utilization disorders, gastrointestinal diseases and liver diseases[1][2].
Web ID
– HY-148795
Shipping
– Room temperature
Molecular Formula
– C26H36N2O5S2
References
– [1]Gillberg Per-Goeran, et al. Preparation of benzothiazepines as liver bile acid transport inhibitors for the treatment of liver, gastrointestinal and other disorders: United States, US20200247769. 2020-08-06.|[2]WHO Drug Information-World Health Organization (WHO).
CAS Number
– 2460667-52-9
Molecular Weight
– 520.70
SMILES
– O=C(CCOC1=C(SC)C=C(N(CC(CCCC)(CCCC)NS2(=O)=O)C3=CC=CC=C3)C2=C1)O
Clinical Information
– No Development Reported
Research Area
– Metabolic Disease; Cardiovascular Disease
Solubility
– 10 mM in DMSO
Target
– Apical Sodium-Dependent Bile Acid Transporter
Pathway
– Membrane Transporter/Ion Channel
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
